Berg T - Search Results

1

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.

Jang H, Yoon JS, Park SY, Lee HA, Jang MJ, Kim SU, Sinn DH, Seo YS, Kim HY, Kim SE, Jun DW, Yoon EL, Sohn JH, Ahn SB, Shim JJ, Jeong SW, Cho YK, Kim HS, Nam JY, Lee YB, Kim YJ, Yoon JH, Zoulim F, Lampertico P, Dalekos GN, Idilman R, Sypsa V, Berg T, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Janssen H, Papatheodoridis GV, Lee JH. Jang H, et al. Among authors: berg t. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1343-1353.e16. doi: 10.1016/j.cgh.2021.09.001. Epub 2021 Sep 6. Clin Gastroenterol Hepatol. 2022. PMID: 34500103

2

Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus.

Berg T, Dirla U, Naumann U, Heuft HG, Küther S, Lobeck H, Schreier E, Hopf U. Berg T, et al. J Hepatol. 1996 Nov;25(5):763-8. doi: 10.1016/s0168-8278(96)80250-9. J Hepatol. 1996. PMID: 8938557 Clinical Trial.

3

Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.

Sarrazin C, Berg T, Lee JH, Teuber G, Dietrich CF, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: berg t. J Hepatol. 1999 Jun;30(6):1004-13. doi: 10.1016/s0168-8278(99)80253-0. J Hepatol. 1999. PMID: 10406177

4

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.

Ahlenstiel G, Berg T, Woitas RP, Grünhage F, Iwan A, Hess L, Brackmann HH, Kupfer B, Schernick A, Sauerbruch T, Spengler U. Ahlenstiel G, et al. Among authors: berg t. J Hepatol. 2003 Aug;39(2):245-52. doi: 10.1016/s0168-8278(03)00193-4. J Hepatol. 2003. PMID: 12873822

5

Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials.

Mangia A, Leandro G, Helbling B, Renner EL, Tabone M, Sidoli L, Caronia S, Foster GR, Zeuzem S, Berg T, Di Marco V, Cino N, Andriulli A. Mangia A, et al. Among authors: berg t. J Hepatol. 2004 Mar;40(3):478-83. doi: 10.1016/j.jhep.2003.11.002. J Hepatol. 2004. PMID: 15123363

6

Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.

Schott E, Witt H, Hinrichsen H, Neumann K, Weich V, Bergk A, Halangk J, Müller T, Tinjala S, Puhl G, Neuhaus P, Wiedenmann B, Berg T. Schott E, et al. Among authors: berg t. J Hepatol. 2007 Mar;46(3):372-80. doi: 10.1016/j.jhep.2006.09.011. Epub 2006 Nov 2. J Hepatol. 2007. PMID: 17150279 Clinical Trial.

7

Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.

Scholz A, Rehm VA, Rieke S, Derkow K, Schulz P, Neumann K, Koch I, Pascu M, Wiedenmann B, Berg T, Schott E. Scholz A, et al. Among authors: berg t. Am J Gastroenterol. 2007 Nov;102(11):2471-81. doi: 10.1111/j.1572-0241.2007.01377.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581268

8

Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.

Schott E, Witt H, Pascu M, van Boemmel F, Weich V, Bergk A, Halangk J, Müller T, Puhl G, Wiedenmann B, Berg T. Schott E, et al. Among authors: berg t. Eur J Gastroenterol Hepatol. 2007 Nov;19(11):947-51. doi: 10.1097/MEG.0b013e3282efa240. Eur J Gastroenterol Hepatol. 2007. PMID: 18049163

9

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.

Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; Hep-Net B/C Co-infection Study Group. Potthoff A, et al. Among authors: berg t. J Hepatol. 2008 Nov;49(5):688-94. doi: 10.1016/j.jhep.2008.03.028. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18490077 Clinical Trial.

10

Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

Halangk J, Sarrazin C, Neumann K, Puhl G, Mueller T, Teuber G, Klinker H, Hinrichsen H, Buggisch P, Landt O, Weich V, Bergk A, Wiedenmann B, Neuhaus P, Berg T, Witt H. Halangk J, et al. Among authors: berg t. J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23. J Hepatol. 2008. PMID: 18644651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,213 results

Search Page